GYRE Latest Press Releases

-- July 16, 2026 --

Gyre Therapeutics Appoints Three New Members to its Board of Directors Globe Newswire 4:05 PM

-- May 12, 2026 --

Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment Globe Newswire 4:05 PM

-- May 7, 2026 --

Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update Globe Newswire 6:00 AM

-- May 4, 2026 --

Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company Globe Newswire 8:47 AM

-- April 20, 2026 --

GYRE THERAPEUTICS: Kaskela Law Announces Investigation of Gyre Therapeutics, Inc. (GYRE) and Encourages Shareholders to Contact the Firm Globe Newswire 9:00 AM

-- March 17, 2026 --

Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment Globe Newswire 7:00 AM

-- March 12, 2026 --

Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 6:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software